Paloma Cejas

9PUBLICATIONS
104CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 07, 2026
Functional epigenomic liquid biopsy identifies potential therapeutic vulnerabilities after enfortumab vedotin-pembrolizumab resistance in metastatic urothelial carcinoma (mUC).

|Nov 12, 2025
EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.

Justine J Jacobi, Kristine M Wadosky, Neha Jaiswal

|Apr 03, 2025
Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer.

Nitin H Shirole, Devishi Kesar, Yenarae Lee

|Feb 05, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer.

Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli

|Jun 26, 2024
Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3.

Marco Seehawer, Zheqi Li, Jun Nishida

|Aug 17, 2023
KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.

Leslie Duplaquet, Yixiang Li, Matthew A Booker

Pageof 2

Frequent Collaborators

8 joint publications

Henry W Long

5 joint publications

Xintao Qiu

3 joint publications

Rong Li

3 joint publications

Sudeepa Syamala